search

Active clinical trials for "Arthritis"

Results 2611-2620 of 3640

Pharmacokinetics and Dosimetry of Tc 99m Tilmanocept Following a Single Intravenous Dose Administration...

ArthritisRheumatoid

A prospective, open-label, single center, study to evaluate pharmacokinetics and dosimetry of intravenously injected Tc 99m tilmanocept at three mass doses (50 µg, 200 µg, and 400 µg) radiolabeled with 10 millicuries (mCi) Tc 99m.

Withdrawn24 enrollment criteria

Eccentric Exercise and Cachexia in Rheumatoid Arthritis

Rheumatoid Arthritis

The purpose of the study is to determine in a randomized controlled trial (RCT), the efficacy of eccentric exercise training in restoring muscle mass and function in patients with rheumatoid cachexia.

Unknown status18 enrollment criteria

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis...

Rheumatoid Arthritis

This observational, prospective, open-label, multi-center study will evaluate the effectiveness in disease reduction and the safety of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthritis. Data will be collected for 11 months.

Terminated4 enrollment criteria

The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis

Rheumatoid Arthritis

This study will evaluate if the combination of resistance exercise and protein supplementation will increase muscle strength and muscle mass among older individuals with rheumatoid arthritis (RA).

Terminated10 enrollment criteria

Long Term Extension Study For SPM-005 Participants

Rheumatoid Arthritis

This will be an open label multicenter study of the safety and efficacy of an active implantable vagal nerve stimulation (VNS) device in patients with rheumatoid arthritis. Patients who complete study SPM-005 will be enrolled in this study at the time of the last visit of the preceding study.

Unknown status3 enrollment criteria

A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients

Rheumatoid Arthritis

This study will treat moderate to severe rheumatoid arthritis with MRC375 (either 75 mg 3 times a day, 150 mg 3 times a day or placebo 3 times a day)in patients 18 years of age or older that can be currently on low doses of methotrexate or can stop treatment of current RA medications to enter the study. Safety of MRC375 will also be evaluated. There are up to 8 clinic visits over 24 weeks.

Unknown status50 enrollment criteria

ROCC Knee Data Collection

Arthritis of Knee

This observational study intends to collect efficacy and safety data on ROCC Knee system.

Terminated6 enrollment criteria

New Tool of Subjective and Objective Functional Evaluation and the Quality of Life After Arthroplastic...

Hip ArthritisKnee Arthritis

Hip or knee arthroplasties allow a relief of pain and a good functional habilitative at patients suffering from degenerative osteoarthritis of these articulations with medium and long-term good results. The main objective of this study is to compare the efficiency in short and medium-term functional impact parlance of two surgical techniques: computer-assisted surgery and mini-invasive surgery compared to the conventional techniques thanks to an innovative technology of ambulatory analysis of walking.

Terminated11 enrollment criteria

Rheumatoid Arthritis Patients in Training

Rheumatoid Arthritis

Aim of the study was to investigate the effectiveness (functional ability and physical capacity) and safety (disease activity and damage of the joints) of long-term high-intensity weight-bearing exercises in patients with rheumatoid arthritis (RA).The training proved to be safe and effective.

Unknown status2 enrollment criteria

The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated...

UveitisArthritis1 more

This study will investigate the safety and effectiveness of the drug Enbrel (TNFR:Fc) to treat uveitis (eye inflammation) in patients with juvenile rheumatoid arthritis.

Unknown status17 enrollment criteria
1...261262263...364

Need Help? Contact our team!


We'll reach out to this number within 24 hrs